WARREN, Mich., May 21, 2025 /PRNewswire/ -- FemCap (https://femcap.com), an FDA-approved, prescription-only contraceptive device, is offering a groundbreaking alternative in the world of birth control ...

Researchers from YourChoice Therapeutics, Columbia University Medical Center and the University of Minnesota reported that ...

SAN DIEGO, June 27, 2024 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (EVFM) (OTCQB: EVFM) today announced a new market partnership with Hello Alpha, a telemedicine company with a ...

A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center ...

SAN FRANCISCO--(BUSINESS WIRE)--YourChoice Therapeutics, Inc., pioneering hormone-free family planning products, today announced that Communications Medicine, a Nature Portfolio Journal, published the ...

BERKELEY, Calif. -- A Berkeley startup says it's developing the first hormone-free birth control for both men and women. Researchers from UC Berkeley founded YourChoice Therapeutics. They say they ...

Women’s reproductive rights in the U.S. are narrowing. Meanwhile, 46% of all pregnancies in the U.S. are unintended, pointing to the stark evidence of the enduring need for access to effective, ...

MINNEAPOLIS — The University of Minnesota College of Pharmacy released research Wednesday that lays the groundwork for the first hormone-free male birth control pill to enter clinical trials.

SAN DIEGO, March 7, 2024 /PRNewswire/ -- Use of GLP-1 receptor agonists, or GLP-1s, is skyrocketing in the United States, with more than nine million prescriptions for Ozempic, Wegovy, Mounjaro, and ...

A non-hormonal, reversible male contraceptive pill with very few side effects might not be as far off as previously thought, early human trial results suggest. In a first-in-human study, a drug called ...